Cambrian Bio to Present Two Posters on ATX-304 at the American Diabetes Association 86th Scientific Sessions

Cambrian Bio will present two posters on ATX-304, a novel pan-AMPK and mitochondrial activator, at ADA 2026 Scientific Sessions.
Medindia

Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes

Over 60% of U.S. adults have risk factors for type 2 diabetes, far more than current diabetes prevention programs can realistically serve. Since diabetes often develops gradually ...

The Best Foods to Help Manage Blood Sugar, According to Dietitians

Dietitians share the best foods to manage blood sugar that won't cause spikes. Plus, smart lifestyle strategies that support ...
Medindia

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

A new study evaluating the role of acmopatide (CT-868), a once-daily dual glucagon-like peptide 1/gastric inhibitory polypeptide receptor ...

How Long Do You Take Wegovy For Weight Loss?

Wegovy is a medication typically prescribed for weight loss and cardiovascular risk reduction individuals with overweight or ...
TMCnet

The American Diabetes Association's Innovation Fund Invests in UpDoc to Accelerate the Future of AI-Driven Chronic Disease Management and Prevention

Today, the American Diabetes Association ® (ADA) announced a strategic investment in UpDoc, an enterprise-ready clinical artificial intelligence (AI) company developing physician-grade agentic AI. The ...
WebMD

Managing Type 2 Diabetes With Mounjaro

People who have type 2 diabetes have an increased amount of sugar in their blood, also called blood glucose. Increased blood sugar happens when your body’s insulin doesn’t work as well as it should.